Cargando…

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology

Detalles Bibliográficos
Autores principales:	Zimmer, Yitzhak, Reinhardt, Hans Christian, Medová, Michaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593708/ https://www.ncbi.nlm.nih.gov/pubmed/33178619 http://dx.doi.org/10.3389/fonc.2020.611127

Ejemplares similares

The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
por: Medová, Michaela, et al.
Publicado: (2013)

A Comparative Analysis of Individual RAS Mutations in Cancer Biology
por: Muñoz-Maldonado, Carmen, et al.
Publicado: (2019)

Editorial: Clinically prediction models for gastrointestinal cancer diagnosis and prognosis in the era of precision oncology
por: Gao, Yinyan, et al.
Publicado: (2023)

Editorial: Precision Medicine in Oncology
por: Re, Angela, et al.
Publicado: (2018)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Editorial: The promise of immunogenetics for precision oncology
por: Vlachonikola, Elisavet, et al.
Publicado: (2023)

Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology
por: Shaw, Ashley, et al.
Publicado: (2022)

Editorial: Precision Medicine and Translational Research in Urological Oncology
por: Na, Rong, et al.
Publicado: (2022)

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
por: Poliaková, Michaela, et al.
Publicado: (2018)

Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
por: Bensimon, Ariel, et al.
Publicado: (2020)

A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response
por: Koch, Jonas P., et al.
Publicado: (2023)

Hope in the era of precision oncology: a qualitative study of informal caregivers’ experiences
por: Kenny, Katherine, et al.
Publicado: (2023)

Editorial: Grappling with the Multifaceted World of the DNA Damage Response
por: Porro, Antonio
Publicado: (2016)

Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
por: Tse, Ka Yu, et al.
Publicado: (2022)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology
por: Shui, Lin, et al.
Publicado: (2021)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
por: Hovhannisyan, Lusine, et al.
Publicado: (2023)

Posttranscriptional regulation of gene expression—adding another layer of complexity to the DNA damage response
por: Boucas, Jorge, et al.
Publicado: (2012)

Circulating tumor DNA analysis in the era of precision oncology
por: Said, Rabih, et al.
Publicado: (2020)

DNA-protein biomarkers for immunotherapy in the era of precision oncology
por: Kim, Binnari, et al.
Publicado: (2021)

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
por: Valvo, Victoria, et al.
Publicado: (2023)

Artificial Intellgence in the Era of Precision Oncological Imaging
por: Cellina, Michaela, et al.
Publicado: (2022)

Editorial: Methods in neuro-oncology and neurosurgical oncology
por: Zoli, Matteo, et al.
Publicado: (2023)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases
por: Turchi, John J., et al.
Publicado: (2022)

Precision oncology for RET-related tumors
por: Verrienti, Antonella, et al.
Publicado: (2022)

Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection
por: Bahado-Singh, Ray, et al.
Publicado: (2022)

Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021
por: Sulman, Erik P., et al.
Publicado: (2023)

Editorial: Charged Particles in Oncology
por: Durante, Marco, et al.
Publicado: (2017)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Editorial: Methods in gynecological oncology
por: Perelli, Federica, et al.
Publicado: (2023)

Editorial: Methods in thoracic oncology
por: Stojšić, Jelena, et al.
Publicado: (2023)

Editorial: Reviews in thoracic oncology
por: Kanellakis, Nikolaos I.
Publicado: (2023)

Editorial: Innovations in surgical oncology
por: Aramini, Beatrice, et al.
Publicado: (2023)

Editorial: Reviews in radiation oncology
por: Lee, David Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_naoric1ls13buptr3m97hctnvv